Asahi Kasei Bioprocess

Move beyond slides and guidelines—see how virus filtration really works in your DSP. At NIBRT on 11 November 2026, we’ll cover Planova™ principles, process design, and operational practices, then connect them to practical implementation from laboratory trials to manufacturing runs. Join us to sharpen your team’s skills and reinforce your viral safety strategy.

Follow Asahi Kasei Bioprocess for the latest insights on virus filtration, microfiltration, process intensification, and advanced bioprocess solutions. Join our community to stay informed about industry trends, technical expertise, and new innovations shaping the future of biomanufacturing.

Follow us to stay ahead in bioprocessing. Discover expert insights, industry trends, and innovations in advanced filtration technology from Asahi Kasei Bioprocess. From viral safety to process intensification, we share the knowledge and technologies helping biopharmaceutical manufacturers address today's challenges and prepare for tomorrow's opportunities.

We're pleased to invite you to an in-person seminar hosted by Biotech Academy in Rome and presented by Asahi Kasei Bioprocess. 𝐈𝐦𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐢𝐧𝐠 𝐕𝐢𝐫𝐮𝐬 𝐅𝐢𝐥𝐭𝐫𝐚𝐭𝐢𝐨𝐧: 𝐏𝐫𝐢𝐧𝐜𝐢𝐩𝐥𝐞𝐬, 𝐕𝐢𝐫𝐚𝐥 𝐒𝐚𝐟𝐞𝐭𝐲, 𝐚𝐧𝐝 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐏𝐫𝐚𝐜𝐭𝐢𝐜𝐞𝐬 𝐟𝐫𝐨𝐦 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐭𝐨 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐒𝐜𝐚𝐥𝐞. If you work in viral safety, downstream processing, or manufacturing, you'll want to learn about the practical implementation of filtration systems at both laboratory and manufacturing scales. This session will cover hands-on technical insights, filter integrity testing, and real-world applications using the latest 𝐏𝐥𝐚𝐧𝐨𝐯𝐚™ technologies. 14 October 2026 9:30 – 16:00 Via di Castel Romano, 100 | 00128 Rome, Italy Limited to 20 participants. Registration link: https://lnkd.in/dpP34WWB Hashtag#Bioprocessing Hashtag#VirusFiltration Hashtag#ViralSafety Hashtag#Biotech

Join us in Cologne for a Complimentary 1.5-day seminar focused on: Planova 20N to S20N Transition: Impact on Performance, Operational Practices, Viral Safety Efficiency and Regulatory requirements for post approval filter change. 📅 30 September – 1 October 2026 📍 CTC, Cologne, Germany Discover the latest advancements in bioprocessing at Asahi Kasei Bioprocess's exclusive CTC Seminar. This interactive seminar combines expert presentations with hands-on training and featured insights from both our specialists and invited guest speakers. Tailored for professionals in Virus Safety, R&D, Process Development and Manufacturing, the program offers practical and scientific guidance on the successful implementation of Planova S20N. 👉 Secure your spot today! https://lnkd.in/eaaKbe39 #AsahiKaseiBioprocess #Planova #Team

We are pleased to announce the expansion of our BioOptimal™ microfilter lineup. As perfusion and intensified upstream processing continue to advance in monoclonal antibody manufacturing, the need for high-performance cell clarification solutions is increasing. BioOptimal microfilters are designed to support high product recovery, stable long-term operation, and scalability from process development to GMP manufacturing. With this lineup expansion, two new products—BioOptimal UMP and BioOptimal UJP—have been added alongside BioOptimal MF-SL, providing broader options for N and N-1 perfusion applications. The expanded BioOptimal lineup offers: ・High product sieving to support improved yield ・Reduced fouling for stable long-term operation ・Scalable performance from process development to GMP manufacturing BioOptimal UMP is designed for TFF applications in perfusion culture and has maintained >90% product seving during 32 days of persusion culture in TFF mode during internal evaluation under high-density cell culture conditions. BioOptimal UJP is designed for N-1 perfusion applications and supports stable, long-duration filtration even under high-flux conditions. Through this expanded lineup, Asahi Kasei Life Science continues to support more robust, efficient, and scalable perfusion processes.